Xiaflex 0.9 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQSU1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,189
Award facts
- Contract value 100% obligated
- $25,189.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,189.38 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xiaflex 0.9 mg vials. The award, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense healthcare operations worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability as a critical supplier within the military pharmaceutical supply chain, holding a single-award IDC valued at $499,999,999 under PPV-G GEN V with a completion date of December 31, 2036. The contract structure includes a 30-month base period with three 30-month option periods, positioning the company to serve as a regional prime vendor contractor supplying branded and generic prescription medications, biologics, over-the-counter drugs, and specialty pharmaceuticals to military healthcare facilities. The vendor's established performance on numerous delivery orders across diverse therapeutic categories, combined with its small business status and longstanding registration in the System for Award Management since 2001, supports its role as a key pharmaceutical supplier for Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FQSU1?
SPE2DR26FQSU1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQSU1 worth?
The government has obligated $25,189 on SPE2DR26FQSU1.
Is contract SPE2DR26FQSU1 an order under another contract?
Yes. SPE2DR26FQSU1 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSU1 competed?
The extent of competition for SPE2DR26FQSU1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award